UNSPSC 51172467: Dehydrocholic acid/homatropine/phenobarbital

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA900. This VA Drug Class (GA900) classifies this compound as belonging to the group GASTRIC MEDICATIONS, OTHER.

UNSPSC 51172467 Dehydrocholic acid/homatropine/phenobarbital is a Commodity code that in recent state and local activity does not align with the specific pharmaceutical formulation named in the code. The recent opportunities tagged under this code instead reflect broader pharmaceutical procurement spanning offender drug-testing services, direct-to-manufacturer prescription programs, and generic multi-source pharmaceuticals and over-the-counter products. Issuing bodies include county corrections departments (Collin County Community Supervision and Corrections Department in Texas), state health and human services agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving state, county, and municipal facilities across multiple states including Oregon). The mix reflects both single-jurisdiction demand and cooperative buying vehicles that aggregate purchasing power across state and local members.

Recent opportunities show concentrated activity in Texas and the upper Midwest with multistate reach. Collin County is soliciting via RFP 2026-327, due July 23, 2026, for offender specimen collection and drug testing services with an estimated contract value of $600,000 across two years plus optional renewals, requiring lab certification from SAMHSA, Texas DPS, or CAP and supporting approximately 25,031 tests annually across five-panel and six-panel immunoassay screening with LC/MS/MS or GC/MS confirmation. Texas Health and Human Services Commission issued RFI HHS0017013, posted April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels—an exploratory phase without formal evaluation criteria or award values. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802, due March 26, 2026, for generic multi-source pharmaceuticals and OTC products through authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, Morris & Dickson) serving state and local government facilities with contract effectiveness July 1, 2026, scoring price competitiveness at 75 percent and requiring cGMP and DSCSA compliance with insurance thresholds reaching $5,000,000 per occurrence for commercial general liability.